Post by TB Alliance

For decades, breakthrough TB treatments have taken years to reach the people who need them most. A new peer-reviewed study shows that doesn’t have to be the case. Our approach to access helped accelerate the uptake of new treatments from nearly a decade to just three years. The takeaway? Access isn’t the last step of innovation – it’s an integral part of the development process. Read more: https://lnkd.in/eBhQtXEe #EndTB #Tuberculosis #GlobalHealth #6MonthsMax Geneva Graduate Institute